Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Acne in Pediatrics: When to Worry?
Description
The presentation discusses the complexities of managing acne in pediatric patients and highlights various concerns from both medical practitioners and families. It begins by emphasizing the effectiveness of available therapies, including newer options such as a triple combination topical treatment that could reduce the reliance on oral antibiotics. Moreover, it acknowledges the barriers to care, particularly the socio-economic factors that affect access to dermatological services and medications. The speaker notes that there is often fear and misinformation surrounding treatments, particularly hormonal therapies, as families express concern about oral contraceptives and issues related to adolescent sexual health. Specific attention is given to managing severe cases, like acne fulminans, and the importance of considering both traditional and innovative treatment options while addressing the influence of social media on patients' perceptions of acne. Ultimately, while acne can be a source of anxiety for patients and their families, the clinician aims to provide informed and comprehensive care, adapting to both clinical advancements and societal challenges.
View moreConclusions
- Acne in pediatric patients is generally manageable with a variety of effective therapies available.
- A triple-combination treatment can significantly improve outcomes without the need for oral antibiotics in many cases.
- Socioeconomic factors play a significant role in access to acne care among pediatric patients, influencing treatment outcomes.
- There remains a persistent issue with medication adherence and misinformation, particularly exacerbated by social media.
- The growing popularity of spironolactone is noted, yet its efficacy and safety remain uncertain, especially in younger populations.
- Acne fulminans is a severe condition that requires careful management, especially regarding isotretinoin use.
- Social stigma associated with acne has a profound impact on individuals' psychological well-being and self-perception.
- Ongoing research and innovative therapies are crucial for improving the management of acne and addressing patient concerns effectively.
- Erlich M et al. J Colloid Interface Science. 2020;579:778-785
- Eichenfield LF et al. Poster: Soc Ped Dermatol 2022; July
- Stein Gold L et al. J Am Acad Dermatol. 2023 Nov;89(5):927-935
- Eichenfield DZ, Sprague J, Eichenfield LF. JAMA. 2021 Nov 23;326(20):2055-2067. doi: 10.1001/jama.2021.1763.
- Rodriguez Baisi KE et al. Pediatr Dermatol 2023 May-Jun:40(3):460-465
- Schneider A et al. Antibiotics (Basel). 2023 Jan 28;12(2):269
- Horissian M, Maczuga S et al. J Am Acad Dermatol 2022;87:684-686
- Bommareddy K et al. JAMA Derm 2022;1:159:275-282
- Dessinioti C et al. JEADV J Eur Acad Dermatol Venereol. 2024 Jan;38(1):197-204
- Gier H et al. 2023; DOI: 10.7759/Cureus.50352
- Shields A et al. JAMA Derm online December 6, 2023. doi:10.1001/